Zobrazeno 1 - 10
of 50
pro vyhledávání: '"M. Yondorf"'
Autor:
Theodore H. Schwartz, Albert Sabbas, M. Yondorf, Andrew W. Smith, Bhupesh Parashar, Shahdabul Faraz, A. Gabriella Wernicke
Publikováno v:
Journal of Contemporary Brachytherapy
Journal of Contemporary Brachytherapy, Vol 12, Iss 4, Pp 311-316 (2020)
Journal of Contemporary Brachytherapy, Vol 12, Iss 4, Pp 311-316 (2020)
Purpose To compare treatment plans and evaluate dosimetric characteristics of permanent cesium-131 (131Cs) vs. iodine-125 (125I) implants used in brain brachytherapy. Material and methods Twenty-four patients with 131Cs implants from a prospective ph
Autor:
Theodore H. Schwartz, A.G. Wernicke, Albert Sabbas, Shoshana Taube, Susan C. Pannullo, M. Yondorf, D.B. Vanderbilt, Lazow Sp, D.A. Julie
Publikováno v:
Journal of neurosurgery. 134(5)
OBJECTIVE Adjuvant radiation therapy (RT), such as cesium-131 (Cs-131) brachytherapy or stereotactic radiosurgery (SRS), reduces local recurrence (LR) of brain metastases (BM). However, SRS is less efficacious for large cavities, and the delay betwee
Autor:
J.M. Mann, A. Gabriella Wernicke, Elizabeth Reznik, M. Yondorf, Andrew W. Smith, Shoshana Taube, Bhupesh Parashar
Publikováno v:
American Journal of Clinical Oncology. 41:197-212
High-grade glioma is the most common primary brain tumor, with glioblastoma multiforme (GBM) accounting for 52% of all brain tumors. The current standard of care (SOC) of GBM involves surgery followed by adjuvant fractionated radiotherapy and chemoth
Autor:
A.G. Wernicke, Theodore H. Schwartz, Albert Sabbas, S Trichter, Shoshana Taube, Rohan Ramakrishna, Ilhami Kovanlikaya, F Kulidzhanov, Dattatreyudu Nori, L. Nedialkova, Andrew W. Smith, Cole B. Hirschfeld, M. Yondorf, Susan C. Pannullo, Philip E. Stieg
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 98:1059-1068
Purpose Studies on adjuvant stereotactic radiosurgery to the cavity of resected brain metastases have suggested that larger tumors (>2.0 cm) have greater rates of recurrence and radionecrosis (RN). The present study assessed the effect of permanent l
Autor:
D.B. Vanderbilt, D.A. Julie, S.P. Lazow, S. Taube, M. Yondorf, A.M. Sabbas, S. Pannullo, T.H. Schwartz, A.G. Wernicke
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e731-e732
Autor:
Shoshana Taube, Theodore H. Schwartz, A. Gabriella Wernicke, John A. Boockvar, Paul J. Christos, Dattatreyudu Nori, Stefanie P Lazow, M. Yondorf, Ilhami Kovanlikaya, Susan C. Pannullo, Philip E. Stieg
Publikováno v:
Operative Neurosurgery. 12:49-60
BACKGROUND Cesium-131 (Cs-131) brachytherapy is used to reduce local recurrence of resected brain metastases. In order to ensure dose homogeneity and reduce risk of radiation necrosis, inter-seed distance and cavity volume must remain stable during d
Autor:
K. S. Clifford Chao, Bhupesh Parashar, Dattatreyudu Nori, John A. Boockvar, Susan C. Pannullo, A. Gabriella Wernicke, M. Yondorf, Philip E. Stieg, Theodore H. Schwartz
Publikováno v:
Journal of Neuro-Oncology. 127:145-153
This study aims to evaluate the cost-effectiveness of surgical resection (S) and Cesium-131 (Cs-131) [S + Cs-131] intraoperative brachytherapy versus S and stereotactic radiosurgery (SRS) [S + SRS] for the treatment of brain metastases. Treatment rec
Autor:
K. S. Clifford Chao, M. Yondorf, Dattatreyudu Nori, John A. Boockvar, Ronald J. Scheff, A. Gabriella Wernicke, Philip E. Stieg, Bhupesh Parashar, Jason C. Ye, Susan C. Pannullo, Theodore H. Schwartz
Publikováno v:
Journal of Radiation Oncology. 4:19-27
Objective This study reports the initial results of hypofractionated radiation therapy (HFRT) with concurrent/adjuvant temozolomide (TMZ) for glioblastoma multiforme (GBM) patients with especially poor prognoses.
Autor:
Shoshana Taube, Bhupesh Parashar, A. Gabriella Wernicke, Paul J. Christos, Andrew W. Smith, Lucy Nedialkova, Liana Greer, Samuel Trichter, Susan C. Pannullo, M. Yondorf, Albert Sabbas
Publikováno v:
Cureus
Introduction Patients with glioblastoma multiforme (GBM) over age 65 represent nearly half of those diagnosed per annum. They have a different tumor markers profile, physiologic reserve, and a median survival as low as three to four months. An optima
Autor:
Dattatreyudu Nori, Lucy Nedialkova, John A. Boockvar, Albert Pavese, Bhupesh Parashar, Philip E. Stieg, M. Yondorf, A. Gabriella Wernicke, K. S. Clifford Chao, Samuel Trichter, Susan C. Pannullo, Theodore H. Schwartz, Albert Sabbas
Publikováno v:
Health physics. 112(4)
Cesium-131 (Cs) brachytherapy is a safe and convenient treatment option for patients with resected brain tumors. This study prospectively analyzes radiation exposure in the patient population who were treated with a maximally safe neurosurgical resec